Genetic Analysis AS (FRA:8V8) Ending Cash Position : €1.42 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Genetic Analysis AS Ending Cash Position?

Genetic Analysis AS's Ending Cash Position for the quarter that ended in Dec. 2023 was €1.42 Mil.

Genetic Analysis AS's quarterly Ending Cash Position declined from Jun. 2023 (€1.02 Mil) to Sep. 2023 (€0.85 Mil) but then increased from Sep. 2023 (€0.85 Mil) to Dec. 2023 (€1.42 Mil).

Genetic Analysis AS's annual Ending Cash Position declined from Dec. 2021 (€4.61 Mil) to Dec. 2022 (€2.42 Mil) and declined from Dec. 2022 (€2.42 Mil) to Dec. 2023 (€1.42 Mil).

Genetic Analysis AS Ending Cash Position Historical Data

The historical data trend for Genetic Analysis AS's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetic Analysis AS Ending Cash Position Chart

Genetic Analysis AS Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

0.40

2.28

4.61

2.42

1.42

Genetic Analysis AS Quarterly Data
	Dec19	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Ending Cash Position	Get a 7-Day Free Trial										2.42	1.53	1.02	0.85	1.42

Genetic Analysis AS Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Genetic Analysis AS's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	2.201	+	-0.785
	=	1.42

Genetic Analysis AS's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0.848	+	0.568
	=	1.42

Genetic Analysis AS Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Genetic Analysis AS's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Genetic Analysis AS (FRA:8V8) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetic Analysis AS (FRA:8V8) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

GEAN:Sweden

Address

Kabelgata 8, Oslo, NOR, 0580

Website

https://www.genetic-analysis.com

Genetic Analysis AS is a research-driven diagnostic company dedicated to delivering innovative diagnostic solutions to the growing human microbiota market. It is providing a CE-marked gut microbiota analysis for testing bacterial imbalance in IBS and IBD patients.

Genetic Analysis AS (FRA:8V8) Headlines

No Headlines